Pharmaceutical revenues were down slightly; so was R&D spending, thanks to a strengthening dollar. Scrip analyzes 620 companies and uses numbers, clocks and tiers to paint some data pictures of the pharmaceutical industry in 2015.
The full Scrip 100 data set for 2017 is now available and includes data on R&D Spending, Total Revenues, Assets, Operating Profit and Sales for 620 biopharmaceutical companies.
If you are a Scrip subscriber, click here to download the data in Excel format.
If you are a non-subscriber please click here, and we can direct you to a taste of the Scrip 100.
Chapter sponsored by:
You must sign in to use this functionality.
Please Sign In
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with active subscriptions will be able to access the full article. All other readers will be directed to the abstract and may purchase the article.